Barbara Eichhorst - University of Cologne

Ellinor Goergen, Julia v. Tresckow,Adam Giza, Sandra Robrecht, Anna-Maria Fink, Kirsten Fischer, Othman Al-Sawaf, Moritz Fürstenau,Florian Simon, Nadine Kutsch, Pascal Nieper,Eugen Tausch, Matthias Ritgen, Sebastian Böttcher, Karl-Anton Kreuzer,Stephan Stilgenbauer, Petra Langerbeins,Barbara Eichhorst,Michael Hallek, Paula Cramer

Clinical Lymphoma Myeloma and Leukemia (2024)

Cited0Views0Bibtex

Six-year Follow-Up and Subgroup Analyses of a Phase 2 Trial of Venetoclax for Del(17p) Chronic Lymphocytic Leukemia

Stephan Stilgenbauer,Eugen Tausch,Andrew W. Roberts,Matthew S. Davids,Barbara Eichhorst,Michael Hallek,Peter Hillmen,Christof Schneider,Johannes Schetelig,Sebastian Boettcher,Arnon P. Kater,Yanwen Jiang,Michelle Boyer,Relja Popovic, Majd T. Ghanim, Michael Moran,Wendy J. Sinai, Xifeng Wang,Nabanita Mukherjee,Brenda Chyla,William G. Wierda,John F. Seymour

Blood advancesno. 8 (2024): 1992-2004

Cited0Views0WOSBibtex

ESMO Clinical Practice Guideline Interim Update on New Targeted Therapies in the First-Line and at Relapse of Chronic Lymphocytic Leukaemia

B. Eichhorst,P. Ghia,C. U. Niemann,A. P. Kater,M. Gregor,M. Hallek,M. Jerkeman,C. Buske

ANNALS OF ONCOLOGY（2024）

Cited0Views0WOSBibtex

CLL-465 Second Primary Malignancies (spms) in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of a Targeted Agent with an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG)

Ellinor Goergen, Julia v. Tresckow,Adam Giza, Sandra Robrecht, Anna-Maria Fink, Kirsten Fischer, Othman Al-Sawaf, Moritz Moritzürstenau,Florian Simon, Nadine Kutsch, Pascal Nieper,Eugen Tausch, Matthias Ritgen, Sebastian Sebastianöttcher, Karl-Anton Kreuzer,Stephan Stilgenbauer, Petra Langerbeins,Barbara Eichhorst,Michael Hallek, Paula Cramer

Clinical Lymphoma Myeloma and Leukemia (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn